ALT
Price
$6.47
Change
-$0.34 (-4.99%)
Updated
Sep 27 closing price
37 days until earnings call
TGTX
Price
$23.83
Change
+$0.50 (+2.14%)
Updated
Sep 27 closing price
44 days until earnings call
Ad is loading...

ALT vs TGTX

Header iconALT vs TGTX Comparison
Open Charts ALT vs TGTXBanner chart's image
Altimmune
Price$6.47
Change-$0.34 (-4.99%)
Volume$2.88M
CapitalizationN/A
TG Therapeutics
Price$23.83
Change+$0.50 (+2.14%)
Volume$1.78M
CapitalizationN/A
View a ticker or compare two or three
ALT vs TGTX Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALT vs. TGTX commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and TGTX is a StrongBuy.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (ALT: $6.38 vs. TGTX: $22.61)
Brand notoriety: ALT and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 82% vs. TGTX: 176%
Market capitalization -- ALT: $459.83M vs. TGTX: $3.69B
ALT [@Biotechnology] is valued at $459.83M. TGTX’s [@Biotechnology] market capitalization is $3.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TGTX is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 5 bearish.
  • TGTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ALT and TGTX are a bad buy in the short-term.

Price Growth

ALT (@Biotechnology) experienced а -4.78% price change this week, while TGTX (@Biotechnology) price change was -2.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

ALT is expected to report earnings on Nov 05, 2024.

TGTX is expected to report earnings on Nov 12, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($3.69B) has a higher market cap than ALT($460M). TGTX YTD gains are higher at: 32.377 vs. ALT (-43.289). ALT has less debt than TGTX: ALT (552K) vs TGTX (112M).
ALTTGTXALT / TGTX
Capitalization460M3.69B12%
EBITDAN/AN/A-
Gain YTD-43.28932.377-134%
P/E RatioN/A35.04-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt552K112M0%
FUNDAMENTALS RATINGS
ALT vs TGTX: Fundamental Ratings
ALT
TGTX
OUTLOOK RATING
1..100
1575
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
7863
SMR RATING
1..100
9767
PRICE GROWTH RATING
1..100
5136
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALT's Valuation (84) in the Miscellaneous Commercial Services industry is in the same range as TGTX (84) in the Biotechnology industry. This means that ALT’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (63) in the Biotechnology industry is in the same range as ALT (78) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's SMR Rating (67) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as ALT (51) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's P/E Growth Rating (99) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTTGTX
RSI
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Stochastic
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Declines
ODDS (%)
Bearish Trend about 2 months ago
0%
Bearish Trend about 2 months ago
0%
BollingerBands
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Aroon
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with EDIT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-4.78%
EDIT - ALT
43%
Loosely correlated
-6.68%
PLRX - ALT
42%
Loosely correlated
-3.84%
INZY - ALT
42%
Loosely correlated
-5.60%
PCVX - ALT
41%
Loosely correlated
+36.39%
PRTA - ALT
41%
Loosely correlated
-4.63%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with EDIT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-3.75%
EDIT - TGTX
48%
Loosely correlated
-6.68%
NTLA - TGTX
47%
Loosely correlated
-3.65%
CRSP - TGTX
43%
Loosely correlated
-4.61%
ABCL - TGTX
40%
Loosely correlated
-2.34%
ALT - TGTX
39%
Loosely correlated
-4.78%
More